Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | VDR | P11473 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | HPGD | P15428 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30219494 | 1.00 | GAA (0.52) | GAAVDRALDH1A1MAPTKDM4E | |
| SCHEMBL13495401 | 0.82 | MAOA (0.43) | GAAVDRALDH1A1MAPTKDM4E | |
| SCHEMBL10040988 | 0.81 | TDP1 (0.60) | GAAALDH1A1MAPTKDM4EHPGD | |
| SCHEMBL12540917 | 0.80 | NPC1 (0.42) | ALDH1A1MAPTKDM4EHPGDKMT2A | |
| SCHEMBL262472 | 0.79 | GAA (0.56) | GAAVDRALDH1A1MAPTKDM4E | |
| SCHEMBL20768726 | 0.79 | GAA (0.56) | GAAVDRALDH1A1MAPTKDM4E | |
| SCHEMBL13495404 | 0.79 | MAOA (0.41) | GAAVDRALDH1A1MAPTKDM4E | |
| SCHEMBL24168448 | 0.78 | MEN1 (0.59) | GAAVDRALDH1A1MAPTKDM4E | |
| SCHEMBL13495402 | 0.78 | CYP2D6 (0.50) | GAAALDH1A1KDM4EHPGDKMT2A | |
| SCHEMBL13495393 | 0.78 | DPP4 (0.47) | ALDH1A1KMT2APOLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 268 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115672395-B | Catalyst system and method for preparing 2-nitro-4-methylsulfonyl benzoic acid by catalytic oxidation | 宁夏伟创药业有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-115672395-A | Catalyst system and method for preparing 2-nitro-4-methylsulfonylbenzoic acid by catalytic oxidation | 宁夏伟创药业有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-112410965-B | Fluorescent flame-retardant arc-proof yarn, preparation method thereof and fabric | 常熟市宝沣特种纤维有限公司 | 2021-12-07 | — | — | CN | claimed |
| CN-112410965-A | Fluorescent flame-retardant arc-proof yarn, preparation method thereof and fabric | 常熟市宝沣特种纤维有限公司 | 2021-02-26 | — | — | CN | claimed |
| EP-1028124-B2 | Improved deprotection method for the synthesis of oligomeric compounds | ISIS PHARMACEUTICALS INC (US) | 2016-01-27 | — | — | EP | claimed |
| EP-1028124-B1 | Improved deprotection method for the synthesis of oligomeric compounds | ISIS PHARMACEUTICALS INC (US) | 2007-10-31 | — | — | EP | claimed |
| US-20050137391-A1 | Process for the synthesis of oligomeric compounds | IONIS PHARMACEUTICALS, INC. | 2005-06-23 | — | — | US | claimed |
| US-20030088088-A1 | Process for the synthesis of oligomeric compounds | IONIS PHARMACEUTICALS, INC. | 2003-05-08 | — | — | US | claimed |
| EP-1028124-A2 | Improved process for the synthesis of oligomeric compounds | ISIS PHARMACEUTICALS, INC. (US) | 2000-08-16 | — | — | EP | claimed |
| EP-4562002-A1 | SUBSTITUTED BICYCLIC HETEROARYL SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF CANCER | Nodus Oncology Limited (GB) | 2025-06-04 | — | — | EP | disclosed |
| CN-115672395-B | Catalyst system and method for preparing 2-nitro-4-methylsulfonyl benzoic acid by catalytic oxidation | 宁夏伟创药业有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-115672395-B | Catalyst system and method for preparing 2-nitro-4-methylsulfonyl benzoic acid by catalytic oxidation | 宁夏伟创药业有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-117777005-A | Synthesis method of N-aryl phthalimide compound | 清源创新实验室 | 2024-03-29 | — | — | CN | disclosed |
| WO-2024023330-A1 | SUBSTITUTED BICYCLIC HETEROARYL SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF CANCER | NODUS ONCOLOGY LIMITED (GB) | 2024-02-01 | — | — | WO | disclosed |
| EP-1028124-A2 | Improved process for the synthesis of oligomeric compounds | ISIS PHARMACEUTICALS, INC. (US) | 2000-08-16 | — | — | EP | disclosed |
| EP-0927717-A1 | PROCESS FOR PRODUCING HYDROPEROXIDES | Mitsui Chemicals, Inc. (JP) | 1999-07-07 | — | — | EP | disclosed |
| US-5789434-A | ACID, ESTER OR AMIDE DERIVATIVES AS ANTIINFLAMMATORY AGENTS, ANTIARTHRITIC AGENTS AND REDUCTION OF CARTILAGE DETERIORATION | BAYER CORPORATION (US) | 1998-08-04 | — | — | US | disclosed |
| US-5001115-A | Prodrugs of biologically active hydroxyaromatic compounds | UNIVERSITY OF FLORIDA (US) | 1991-03-19 | — | — | US | disclosed |
| EP-0046064-A1 | Non-silver image-forming composition | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1982-02-17 | — | — | EP | disclosed |
| US-4308341-A | PROVIDING ISOINDOZE DYES BY REACTION OF COBALT AMINE LIGANDS AND AROMATIC DIALDEHYDES | EASTMAN KODAK COMPANY (US) | 1981-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050137391-A1 | Process for the synthesis of oligomeric compounds | PFAS, DIS3, EXOSC4 | GAA 2656/4885VDR 4540/4885ALDH1A1 3004/4885 |
| US-20030088088-A1 | Process for the synthesis of oligomeric compounds | PFAS, DIS3, EXOSC4 | GAA 2656/4885VDR 4540/4885ALDH1A1 3004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.